{"hands_on_practices": [{"introduction": "A cornerstone of diagnosing Myasthenia Gravis is electrodiagnostic testing. This exercise provides practical experience with Repetitive Nerve Stimulation (RNS), a key diagnostic tool that reveals the functional state of the neuromuscular junction. By calculating the percentage decrement in the compound muscle action potential, you will practice quantifying the hallmark physiological sign of postsynaptic transmission failure, a fundamental skill for confirming a suspected diagnosis [@problem_id:4500353].", "problem": "A patient with suspected myasthenia gravis undergoes Repetitive Nerve Stimulation (RNS) of the ulnar nerve at $3\\,\\mathrm{Hz}$, with Compound Muscle Action Potential (CMAP) peak-to-peak amplitudes recorded for the first five responses as $6.0$, $5.4$, $5.0$, $4.8$, and $4.7$ millivolts. In neuromuscular transmission testing, the diagnostic decrement is operationally assessed by comparing later responses to the initial response using the core definition of relative change (the ratio of the change to the initial quantity). Using this principle, determine the percentage decrement from the first to the fourth response. Express your answer as a decimal fraction (not with a percentage sign), and round your answer to four significant figures.", "solution": "The problem requires the calculation of the percentage decrement in Compound Muscle Action Potential (CMAP) amplitude between the first and fourth responses from a Repetitive Nerve Stimulation (RNS) test. The problem provides the necessary data and a clear definition for the calculation.\n\nLet $A_n$ represent the peak-to-peak amplitude of the CMAP for the $n$-th response, measured in millivolts ($\\mathrm{mV}$). The provided sequence of the first five amplitudes is:\n$A_1 = 6.0$\n$A_2 = 5.4$\n$A_3 = 5.0$\n$A_4 = 4.8$\n$A_5 = 4.7$\n\nThe problem asks for the decrement from the first to the fourth response. Let us denote the initial amplitude as $A_{initial}$ and the later amplitude as $A_{later}$. For this specific calculation, we have:\n$A_{initial} = A_1 = 6.0$\n$A_{later} = A_4 = 4.8$\n\nThe problem states that the decrement is assessed using \"the core definition of relative change (the ratio of the change to the initial quantity)\". Let us denote the decrement by the symbol $D$. The change in amplitude is the difference between the initial and later amplitudes, which is $A_{initial} - A_{later}$. The relative change is this difference divided by the initial amplitude.\n\nTherefore, the formula for the decrement $D$ is:\n$$D = \\frac{A_{initial} - A_{later}}{A_{initial}}$$\n\nApplying this formula to the decrement from the first to the fourth response, which we can denote as $D_{1 \\to 4}$, we substitute $A_1$ for $A_{initial}$ and $A_4$ for $A_{later}$:\n$$D_{1 \\to 4} = \\frac{A_1 - A_4}{A_1}$$\n\nNow, we substitute the given numerical values into this equation:\n$$D_{1 \\to 4} = \\frac{6.0 - 4.8}{6.0}$$\n\nFirst, we calculate the numerator, which represents the absolute decrement in amplitude:\n$$6.0 - 4.8 = 1.2$$\n\nNext, we substitute this result back into the expression for $D_{1 \\to 4}$:\n$$D_{1 \\to 4} = \\frac{1.2}{6.0}$$\n\nPerforming the division gives the decrement as a decimal fraction:\n$$D_{1 \\to 4} = 0.2$$\n\nThe problem requires the answer to be expressed as a decimal fraction and rounded to four significant figures. The calculated value is exactly $0.2$. To express this with four significant figures, we must add trailing zeros after the decimal point. The number $0.2000$ has four significant figures (the digits $2$, $0$, $0$, and $0$).\n\nThus, the percentage decrement, expressed as a decimal fraction rounded to four significant figures, is $0.2000$. This value corresponds to a $20\\%$ decrement, which is a common diagnostic threshold in clinical neurophysiology for myasthenia gravis.", "answer": "$$\\boxed{0.2000}$$", "id": "4500353"}, {"introduction": "Once a diagnosis of Myasthenia Gravis is established, the focus shifts to treatment, especially during acute exacerbations. This problem simulates the real-world clinical task of planning an Intravenous Immunoglobulin (IVIG) infusion, a primary therapy for managing severe myasthenic weakness. You will translate a standard weight-based dosing regimen into a practical, multi-step infusion schedule, a critical skill for ensuring both therapeutic efficacy and patient safety by minimizing infusion-related side effects [@problem_id:4500370].", "problem": "A $80\\,\\mathrm{kg}$ adult presents with acute exacerbation of myasthenia gravis and is planned for high-dose Intravenous Immunoglobulin (IVIG) therapy. The standard high-dose regimen is a total dose of $2\\,\\mathrm{g}\\,\\mathrm{kg}^{-1}$ administered over $4$ consecutive days, with equal daily doses. The available IVIG preparation is a $10\\%$ solution, which, by definition of concentration, contains $100\\,\\mathrm{mg}$ IVIG per $\\mathrm{mL}$.\n\nTo minimize infusion-related adverse effects (such as headache, chills, and blood pressure changes), clinicians often employ a conservative stepwise infusion rate escalation. Assume you select the following rate schedule per current safety-conscious practice:\n\n- Start at $0.5\\,\\mathrm{mL}\\,\\mathrm{kg}^{-1}\\,\\mathrm{hr}^{-1}$ for $30\\,\\mathrm{min}$,\n- Increase to $1.0\\,\\mathrm{mL}\\,\\mathrm{kg}^{-1}\\,\\mathrm{hr}^{-1}$ for $30\\,\\mathrm{min}$,\n- Increase to $2.0\\,\\mathrm{mL}\\,\\mathrm{kg}^{-1}\\,\\mathrm{hr}^{-1}$ for $30\\,\\mathrm{min}$,\n- Then continue at $4.0\\,\\mathrm{mL}\\,\\mathrm{kg}^{-1}\\,\\mathrm{hr}^{-1}$ until the full daily volume is delivered.\n\nAssume no interruptions and that the patient tolerates each step without the need to slow or pause the infusion. Using first principles of dose calculation ($\\text{mass} = \\text{dose per kilogram} \\times \\text{body mass}$), the definition of concentration ($C = M/V$), and the relationship between rate and volume ($V = R \\times t$ for a constant rate), compute the cumulative infusion time across all $4$ days under this schedule. Round your final cumulative $4$-day infusion time to four significant figures and express the answer in hours. In your reasoning, you may also outline a premedication plan to minimize adverse effects (e.g., analgesic and antihistamine), but only the cumulative infusion time should be reported as the final answer.", "solution": "The solution proceeds by first calculating the total daily volume of IVIG to be infused. Then, we will calculate the volume delivered during each of the initial fixed-duration steps of the infusion schedule. The remaining volume will determine the duration of the final infusion step. The total time for one day's infusion is then calculated, and finally, this is multiplied by the number of days of treatment.\n\nFirst, we calculate the total mass of IVIG for the entire treatment course.\nLet $M_{total}$ be the total mass, $m$ be the patient's body mass ($80\\,\\mathrm{kg}$), and $D_{total/kg}$ be the prescribed dose per kilogram ($2\\,\\mathrm{g}\\,\\mathrm{kg}^{-1}$).\n$$M_{total} = m \\times D_{total/kg} = 80\\,\\mathrm{kg} \\times 2\\,\\mathrm{g}\\,\\mathrm{kg}^{-1} = 160\\,\\mathrm{g}$$\n\nThis total mass is administered in equal doses over $N_{days} = 4$ days. The daily mass, $M_{daily}$, is:\n$$M_{daily} = \\frac{M_{total}}{N_{days}} = \\frac{160\\,\\mathrm{g}}{4} = 40\\,\\mathrm{g}$$\n\nThe IVIG preparation has a concentration $C = 100\\,\\mathrm{mg}\\,\\mathrm{mL}^{-1}$. We convert the daily mass to milligrams to be dimensionally consistent.\n$$M_{daily} = 40\\,\\mathrm{g} \\times \\frac{1000\\,\\mathrm{mg}}{1\\,\\mathrm{g}} = 40000\\,\\mathrm{mg}$$\n\nThe total volume of the IVIG solution to be infused each day, $V_{daily}$, is calculated using the definition of concentration, $C = M/V$.\n$$V_{daily} = \\frac{M_{daily}}{C} = \\frac{40000\\,\\mathrm{mg}}{100\\,\\mathrm{mg}\\,\\mathrm{mL}^{-1}} = 400\\,\\mathrm{mL}$$\n\nNext, we analyze the stepwise infusion schedule for a single day. The rates are given per kilogram of body mass, so we calculate the absolute infusion rates ($R'_i$) in $\\mathrm{mL}\\,\\mathrm{hr}^{-1}$ by multiplying by the patient's mass, $m = 80\\,\\mathrm{kg}$.\n- Step 1: $R'_1 = R_1 \\times m = 0.5\\,\\mathrm{mL}\\,\\mathrm{kg}^{-1}\\,\\mathrm{hr}^{-1} \\times 80\\,\\mathrm{kg} = 40\\,\\mathrm{mL}\\,\\mathrm{hr}^{-1}$.\n- Step 2: $R'_2 = R_2 \\times m = 1.0\\,\\mathrm{mL}\\,\\mathrm{kg}^{-1}\\,\\mathrm{hr}^{-1} \\times 80\\,\\mathrm{kg} = 80\\,\\mathrm{mL}\\,\\mathrm{hr}^{-1}$.\n- Step 3: $R'_3 = R_3 \\times m = 2.0\\,\\mathrm{mL}\\,\\mathrm{kg}^{-1}\\,\\mathrm{hr}^{-1} \\times 80\\,\\mathrm{kg} = 160\\,\\mathrm{mL}\\,\\mathrm{hr}^{-1}$.\n- Step 4: $R'_4 = R_4 \\times m = 4.0\\,\\mathrm{mL}\\,\\mathrm{kg}^{-1}\\,\\mathrm{hr}^{-1} \\times 80\\,\\mathrm{kg} = 320\\,\\mathrm{mL}\\,\\mathrm{hr}^{-1}$.\n\nThe first three steps have a fixed duration of $30\\,\\mathrm{min}$, which is $0.5\\,\\mathrm{hr}$. We calculate the volume infused in each of these steps ($V_i = R'_i \\times t_i$).\n- Volume in Step 1: $V_1 = 40\\,\\mathrm{mL}\\,\\mathrm{hr}^{-1} \\times 0.5\\,\\mathrm{hr} = 20\\,\\mathrm{mL}$.\n- Volume in Step 2: $V_2 = 80\\,\\mathrm{mL}\\,\\mathrm{hr}^{-1} \\times 0.5\\,\\mathrm{hr} = 40\\,\\mathrm{mL}$.\n- Volume in Step 3: $V_3 = 160\\,\\mathrm{mL}\\,\\mathrm{hr}^{-1} \\times 0.5\\,\\mathrm{hr} = 80\\,\\mathrm{mL}$.\n\nThe total volume infused in these first three steps is:\n$$V_{1-3} = V_1 + V_2 + V_3 = 20\\,\\mathrm{mL} + 40\\,\\mathrm{mL} + 80\\,\\mathrm{mL} = 140\\,\\mathrm{mL}$$\n\nThe remaining volume, $V_4$, to be infused at the final rate $R'_4$ is:\n$$V_4 = V_{daily} - V_{1-3} = 400\\,\\mathrm{mL} - 140\\,\\mathrm{mL} = 260\\,\\mathrm{mL}$$\n\nThe time required for Step 4, $t_4$, is:\n$$t_4 = \\frac{V_4}{R'_4} = \\frac{260\\,\\mathrm{mL}}{320\\,\\mathrm{mL}\\,\\mathrm{hr}^{-1}} = \\frac{26}{32}\\,\\mathrm{hr} = \\frac{13}{16}\\,\\mathrm{hr} = 0.8125\\,\\mathrm{hr}$$\n\nThe total time for one day's infusion, $T_{daily}$, is the sum of the durations of all steps.\n$$T_{daily} = t_1 + t_2 + t_3 + t_4 = 0.5\\,\\mathrm{hr} + 0.5\\,\\mathrm{hr} + 0.5\\,\\mathrm{hr} + 0.8125\\,\\mathrm{hr} = 2.3125\\,\\mathrm{hr}$$\n\nSince the same procedure is repeated for $N_{days} = 4$ days, the cumulative infusion time for the entire treatment, $T_{total}$, is:\n$$T_{total} = T_{daily} \\times N_{days} = 2.3125\\,\\mathrm{hr} \\times 4 = 9.25\\,\\mathrm{hr}$$\n\nThe problem requires the final answer to be rounded to four significant figures.\n$$T_{total} = 9.250\\,\\mathrm{hr}$$\n\nRegarding the optional point on premedication: a premedication plan is a component of clinical practice intended to improve patient tolerance to IVIG. Standard practice to mitigate infusion reactions often involves administering an analgesic/antipyretic (e.g., acetaminophen) and an antihistamine (e.g., diphenhydramine) approximately $30$ to $60$ minutes prior to commencing the infusion. However, the specific agents, doses, and necessity of premedication are determined by institutional protocols and the patient's history of infusion reactions, and are outside the scope of this quantitative problem.", "answer": "$$\n\\boxed{9.250}\n$$", "id": "4500370"}, {"introduction": "The most critical challenge in managing Myasthenia Gravis is recognizing and acting on impending respiratory failure, a condition known as myasthenic crisis. This scenario tests your ability to synthesize clinical signs and quantitative bedside measurements to make a life-saving decision regarding airway management. It emphasizes the importance of interpreting data like forced vital capacity (FVC) and negative inspiratory force (NIF) to intervene proactively, before irreversible decompensation occurs [@problem_id:4500402].", "problem": "A $58$-year-old woman with acetylcholine receptor antibody–positive myasthenia gravis presents with $2\\,\\mathrm{days}$ of worsening dyspnea, dysphagia, and fatigable dysarthria. She is afebrile, with respiratory rate $28\\,\\mathrm{breaths/min}$, pulse oximetry $96\\%$ on room air, use of accessory muscles, and weak palatal elevation with an ineffective cough. Bedside spirometry demonstrates forced vital capacity (FVC) $0.9\\,\\mathrm{L}$, which corresponds to $15\\,\\mathrm{mL/kg}$ for her weight of $60\\,\\mathrm{kg}$, and a negative inspiratory force (NIF) of $-18\\,\\mathrm{cm\\,H_2O}$. \n\nUsing fundamental respiratory physiology, specifically that the inspiratory pump must generate sufficient negative intrathoracic pressure to produce adequate tidal volumes and cough for airway protection, and that alveolar ventilation $V_A$ depends on tidal volume $V_T$ via $V_A = (V_T - V_D)\\times f$, determine the most appropriate immediate management step. Assume no alternative cardiopulmonary disease. \n\nWhich option best justifies the appropriate level of care and airway strategy for this patient?\n\nA. Admit to the intensive care unit (ICU) for close monitoring and prepare for elective endotracheal intubation because the measured FVC per kilogram and NIF indicate high risk for ventilatory failure and inability to protect the airway.\n\nB. Observe on a general ward with serial oximetry because the normal oxygen saturation indicates preserved gas exchange and adequate respiratory reserve despite reduced FVC and NIF.\n\nC. Avoid intubation because a NIF of $-18\\,\\mathrm{cm\\,H_2O}$ reflects sufficient inspiratory strength; initiate noninvasive positive pressure ventilation (NIPPV) on the ward.\n\nD. Administer a high dose of oral pyridostigmine and defer ICU admission because increasing acetylcholine at the neuromuscular junction will rapidly normalize FVC and NIF.\n\nE. Begin intravenous immunoglobulin (IVIg) on the medical floor without airway escalation because immunotherapy will reverse weakness within hours, making advanced airway management unnecessary.", "solution": "## Problem Validation\n\n### Step 1: Extract Givens\n- **Patient Profile:** $58$-year-old woman with acetylcholine receptor antibody–positive myasthenia gravis.\n- **Presenting Symptoms:** $2\\,\\mathrm{days}$ of worsening dyspnea, dysphagia, and fatigable dysarthria.\n- **Clinical Signs:**\n    - Afebrile.\n    - Respiratory rate ($f$): $28\\,\\mathrm{breaths/min}$.\n    - Pulse oximetry ($SpO_2$): $96\\%$ on room air.\n    - Physical exam: use of accessory muscles, weak palatal elevation, ineffective cough.\n- **Quantitative Measurements:**\n    - Patient weight: $60\\,\\mathrm{kg}$.\n    - Forced vital capacity (FVC): $0.9\\,\\mathrm{L}$, which is $15\\,\\mathrm{mL/kg}$.\n    - Negative inspiratory force (NIF): $-18\\,\\mathrm{cm\\,H_2O}$.\n- **Physiological Principles Provided:**\n    - The inspiratory pump must generate sufficient negative intrathoracic pressure for adequate tidal volumes ($V_T$) and cough.\n    - Alveolar ventilation ($V_A$) is given by the formula $V_A = (V_T - V_D) \\times f$, where $V_D$ is dead space volume.\n- **Assumption:** No alternative cardiopulmonary disease.\n- **Question:** Determine the most appropriate immediate management step and its justification.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded:** The problem describes a classic critical care scenario: a myasthenic crisis leading to impending respiratory failure. The variables provided (FVC, NIF, respiratory rate, clinical signs) are standard parameters used in neurology and critical care to assess respiratory muscle strength and the need for ventilatory support. The physiological principles cited are fundamental to respiratory medicine. The clinical picture is entirely consistent with the pathophysiology of myasthenia gravis.\n- **Well-Posed:** The problem provides sufficient, consistent data to make a standard-of-care clinical judgment. The relationship between the patient's FVC ($0.9\\,\\mathrm{L}$) and weight ($60\\,\\mathrm{kg}$) is correctly calculated as $15\\,\\mathrm{mL/kg}$ (since $0.9\\,\\mathrm{L} / 60\\,\\mathrm{kg} = 0.015\\,\\mathrm{L/kg} = 15\\,\\mathrm{mL/kg}$). The call for the \"most appropriate\" step implies a unique best course of action based on established medical guidelines.\n- **Objective:** The problem is stated using objective clinical data and terminology. There are no subjective or ambiguous statements.\n\n### Step 3: Verdict and Action\nThe problem statement is valid. It is scientifically sound, well-posed, and objective, presenting a realistic and formalizable clinical challenge based on established principles of neurology and respiratory physiology. I will proceed with the solution derivation.\n\n## Solution Derivation\n\nThe patient presents with an exacerbation of myasthenia gravis, a condition characterized by antibody-mediated destruction of acetylcholine receptors at the neuromuscular junction, leading to muscle weakness. The current presentation with worsening dyspnea, dysphagia, and signs of respiratory distress constitutes a myasthenic crisis, which is a life-threatening emergency. The decision for management hinges on a careful assessment of respiratory function and airway protection.\n\n**Analysis of Respiratory Status:**\n1.  **Work of Breathing:** The patient's respiratory rate is high at $f = 28\\,\\mathrm{breaths/min}$ (normal is typically $12-20\\,\\mathrm{breaths/min}$), and she is using accessory muscles. These are clear signs of respiratory distress and increased work of breathing. The body is attempting to compensate for inefficient ventilation.\n\n2.  **Alveolar Ventilation ($V_A$):** The governing equation is $V_A = (V_T - V_D) \\times f$. In a state of neuromuscular weakness, the tidal volume ($V_T$) decreases. To maintain adequate alveolar ventilation and prevent $CO_2$ retention (hypercapnia), the patient reflexively increases the respiratory frequency ($f$). This shallow, rapid breathing pattern is inefficient because a larger proportion of each breath ventilates the anatomical dead space ($V_D$), which does not participate in gas exchange. This pattern is unsustainable and is a harbinger of ventilatory failure.\n\n3.  **Measures of Respiratory Muscle Strength:**\n    -   **Forced Vital Capacity (FVC):** This measures the maximum volume of air a person can exhale after a full inspiration. It is a reliable indicator of overall respiratory muscle strength. A normal FVC is approximately $60-70\\ \\mathrm{mL/kg}$. This patient's FVC is $15\\ \\mathrm{mL/kg}$. A value below $20\\ \\mathrm{mL/kg}$ is widely considered a critical threshold indicating severe weakness and a high risk of impending acute ventilatory failure.\n    -   **Negative Inspiratory Force (NIF):** This measures the maximal inspiratory pressure that can be generated against an occluded airway, reflecting the strength of the diaphragm and other inspiratory muscles. A normal NIF is more negative than $-60\\,\\mathrm{cm\\,H_2O}$. A NIF that is less negative than $-20\\,\\mathrm{cm\\,H_2O}$ (e.g., $-18\\,\\mathrm{cm\\,H_2O}$, $-15\\,\\mathrm{cm\\,H_2O}$) indicates critical inspiratory muscle weakness. This patient's NIF of $-18\\,\\mathrm{cm\\,H_2O}$ is below this critical threshold, signifying an inability to generate sufficient negative pressure for an adequate breath or an effective cough.\n\n4.  **Airway Protection:** The patient has dysphagia (difficulty swallowing) and weak palatal elevation. This bulbar weakness, combined with an ineffective cough (a consequence of low inspiratory and expiratory muscle strength), places her at extremely high risk for aspiration of oral secretions or gastric contents. Inability to protect the airway is, in itself, an indication for intubation.\n\n5.  **Pulse Oximetry ($SpO_2$):** The patient's $SpO_2$ of $96\\%$ is misleadingly normal. Acute respiratory failure in neuromuscular disease is primarily *ventilatory* failure (hypercapnic), not oxygenation failure (hypoxic). The patient can maintain normal oxygen saturation early on through tachypnea, at the cost of immense respiratory effort. Hypoxia is a late and pre-arrest finding. Relying on $SpO_2$ as a sign of stability is a common and dangerous clinical error.\n\n**Conclusion:** The combination of clinical signs (tachypnea, accessory muscle use), critically low quantitative measures of respiratory strength (FVC $15\\ \\mathrm{mL/kg}$, NIF $-18\\,\\mathrm{cm\\,H_2O}$), and evidence of bulbar weakness compromising airway protection (dysphagia, weak cough) indicates that the patient is in impending respiratory failure. The most appropriate and safest course of action is to secure the airway via endotracheal intubation on an elective basis, before acute decompensation occurs. This requires management in an intensive care unit (ICU) where close monitoring and mechanical ventilation can be provided.\n\n### Option-by-Option Analysis\n\n**A. Admit to the intensive care unit (ICU) for close monitoring and prepare for elective endotracheal intubation because the measured FVC per kilogram and NIF indicate high risk for ventilatory failure and inability to protect the airway.**\nThis option correctly identifies the severity of the situation. ICU admission is mandatory for a patient with impending respiratory failure. It correctly interprets the FVC ($15\\,\\mathrm{mL/kg}$) and NIF ($-18\\,\\mathrm{cm\\,H_2O}$) as critical values portending ventilatory failure. It also correctly highlights the inability to protect the airway as a key concern. Elective intubation is the standard of care to prevent a more hazardous emergent intubation during a respiratory arrest. This reasoning is physiologically and clinically sound.\n**Verdict: Correct.**\n\n**B. Observe on a general ward with serial oximetry because the normal oxygen saturation indicates preserved gas exchange and adequate respiratory reserve despite reduced FVC and NIF.**\nThis option is fundamentally flawed. It incorrectly interprets normal oxygen saturation as a sign of stability and adequate respiratory reserve. As detailed above, $SpO_2$ is a poor indicator of ventilatory status in this context, and all other signs point to a complete lack of respiratory reserve. Management on a general medical ward would be unsafe.\n**Verdict: Incorrect.**\n\n**C. Avoid intubation because a NIF of $-18\\,\\mathrm{cm\\,H_2O}$ reflects sufficient inspiratory strength; initiate noninvasive positive pressure ventilation (NIPPV) on the ward.**\nThis option contains a critical factual error. A NIF of $-18\\,\\mathrm{cm\\,H_2O}$ reflects profound weakness, not sufficient strength. While NIPPV has a role in some forms of respiratory failure, its use in myasthenic crisis is contentious, particularly in the presence of significant bulbar dysfunction and excessive secretions, due to the high risk of aspiration and inability to form a proper mask seal. Managing such a fragile patient with NIPPV on a general ward is not appropriate.\n**Verdict: Incorrect.**\n\n**D. Administer a high dose of oral pyridostigmine and defer ICU admission because increasing acetylcholine at the neuromuscular junction will rapidly normalize FVC and NIF.**\nThis option proposes a dangerous delay in definitive airway management. Oral pyridostigmine has a slow onset, and its absorption may be impaired in a patient with bulbar dysfunction. It is not potent enough to rapidly reverse a crisis of this magnitude. Moreover, excessive doses can precipitate a cholinergic crisis, worsening weakness and increasing secretions, thereby exacerbating the problem. Deferring ICU admission is inappropriate.\n**Verdict: Incorrect.**\n\n**E. Begin intravenous immunoglobulin (IVIg) on the medical floor without airway escalation because immunotherapy will reverse weakness within hours, making advanced airway management unnecessary.**\nThis option misrepresents the timeline of immunotherapy. While IVIg (or plasma exchange) is the definitive treatment for the underlying immunological attack, its clinical effects are not seen for several days to a week, not \"within hours.\" The patient is at risk of respiratory arrest in the immediate future. Immunotherapy is a crucial part of the treatment plan, but it does not obviate the need for immediate ventilatory support and airway protection.\n**Verdict: Incorrect.**", "answer": "$$\\boxed{A}$$", "id": "4500402"}]}